{"transactions":[{"id":689378,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-08-12T22:00:03.000Z","date":"2026-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 463,167 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":679863,"source":{"system":"sec-edgar","filing":"0001193125-26-347275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526347275/ownership.xml","form_type":"4"}},{"id":848894,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:06.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 503,917 restricted stock units."}],"balance_after":704677,"source":{"system":"sec-edgar","filing":"0001193125-26-102763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526102763/ownership.xml","form_type":"4"}},{"id":848893,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:06.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 509,648 restricted stock units."}],"balance_after":706073,"source":{"system":"sec-edgar","filing":"0001193125-26-102763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526102763/ownership.xml","form_type":"4"}},{"id":910124,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T02:00:03.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":16875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021."}],"balance_after":0,"derivative":{"exercise_price":1.05,"exercise_date":"2021-01-30","expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":16875},"source":{"system":"sec-edgar","filing":"0001193125-26-047313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526047313/ownership.xml","form_type":"4"}},{"id":910123,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-02-12T02:00:03.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":16875,"price":1.05,"value":17718.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 511, 291 restricted stock units."}],"balance_after":706474,"source":{"system":"sec-edgar","filing":"0001193125-26-047313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526047313/ownership.xml","form_type":"4"}},{"id":932445,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":53500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":0.72,"exercise_date":"2020-01-26","expiration_date":"2026-01-26","underlying":"Common Stock","underlying_shares":53500},"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":932444,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 511,291 restricted stock units"}],"balance_after":689599,"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":932443,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":53500,"price":0.72,"value":38520.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 283,948 restricted stock units."}],"balance_after":427099,"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":1012640,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-10-28T21:00:07.000Z","date":"2025-10-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 283,948 restricted stock units."}],"balance_after":373599,"source":{"system":"sec-edgar","filing":"0001193125-25-253801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312525253801/ownership.xml","form_type":"4"}},{"id":1069044,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-08-13T01:30:07.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 284,798 restricted stock units."}],"balance_after":373807,"source":{"system":"sec-edgar","filing":"0000950170-25-107555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025107555/ownership.xml","form_type":"4"}},{"id":1083456,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-22T21:00:09.000Z","date":"2025-07-18","kind":"exercise","planned":false,"acquired":false,"shares":33437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019."}],"balance_after":0,"derivative":{"exercise_price":0.7178,"exercise_date":"2019-07-28","expiration_date":"2025-07-28","underlying":"Common Stock","underlying_shares":33437},"source":{"system":"sec-edgar","filing":"0000950170-25-097601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025097601/ownership.xml","form_type":"4"}},{"id":1083455,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-07-22T21:00:09.000Z","date":"2025-07-18","kind":"exercise","planned":false,"acquired":true,"shares":33437,"price":0.7178,"value":24001.0786,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 325,098 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":383621,"source":{"system":"sec-edgar","filing":"0000950170-25-097601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025097601/ownership.xml","form_type":"4"}},{"id":1197242,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021."}],"balance_after":16875,"derivative":{"exercise_price":1.05,"exercise_date":"2021-01-30","expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1197241,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":7.9692,"value":398460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.8800 to $8.0900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":364081,"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1197240,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.05,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":414081,"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1212510,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:11.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":364081,"source":{"system":"sec-edgar","filing":"0000950170-25-037572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025037572/ownership.xml","form_type":"4"}},{"id":1212509,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:11.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 330,829 restricted stock units."}],"balance_after":365477,"source":{"system":"sec-edgar","filing":"0000950170-25-037572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025037572/ownership.xml","form_type":"4"}},{"id":1295674,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:06.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":140625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 332,473 restricted stock units."}],"balance_after":365878,"source":{"system":"sec-edgar","filing":"0000950170-25-008973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025008973/ownership.xml","form_type":"4"}},{"id":1303567,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:08.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 198,078 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 20,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":225253,"source":{"system":"sec-edgar","filing":"0000950170-25-005580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025005580/ownership.xml","form_type":"4"}},{"id":1406767,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-16T20:30:05.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":false,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.0972,"exercise_date":"2018-12-15","expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0000950170-24-106856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017024106856/ownership.xml","form_type":"4"}},{"id":1406766,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-09-16T20:30:05.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":true,"shares":33750,"price":0.0972,"value":3280.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 215,185 restricted stock units."}],"balance_after":250074,"source":{"system":"sec-edgar","filing":"0000950170-24-106856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017024106856/ownership.xml","form_type":"4"}},{"id":1436988,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-08-10T01:30:04.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":120900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 215,185 restricted stock units."}],"balance_after":216324,"source":{"system":"sec-edgar","filing":"0000950170-24-095009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017024095009/ownership.xml","form_type":"4"}},{"id":1581548,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:30:12.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,285 restricted stock units."}],"balance_after":95424,"source":{"system":"sec-edgar","filing":"0000950170-24-030429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017024030429/ownership.xml","form_type":"4"}},{"id":1581547,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:30:12.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 95,681 restricted stock units."}],"balance_after":96820,"source":{"system":"sec-edgar","filing":"0000950170-24-030429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017024030429/ownership.xml","form_type":"4"}},{"id":1680132,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-13T02:00:10.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":73200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":73200,"derivative":{"exercise_price":13.46,"expiration_date":"2034-01-10","underlying":"Stock Option (Right to Buy)","underlying_shares":73200},"source":{"system":"sec-edgar","filing":"0001209191-24-001589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919124001589/doc4.xml","form_type":"4"}},{"id":1680131,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-01-13T02:00:10.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":65025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,070 RSUs."}],"balance_after":97209,"source":{"system":"sec-edgar","filing":"0001209191-24-001589","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919124001589/doc4.xml","form_type":"4"}},{"id":1749966,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-11-04T01:00:08.000Z","date":"2023-11-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,045 RSUs."}],"balance_after":32184,"source":{"system":"sec-edgar","filing":"0001209191-23-054433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123054433/doc4.xml","form_type":"4"}},{"id":1887027,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-19T01:00:07.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested in equal annual installments over 4 years, commencing on December 15, 2015 with the last installment vesting on December 15, 2018."}],"balance_after":33750,"derivative":{"exercise_price":0.1,"exercise_date":"2018-12-15","expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-030857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123030857/doc4.xml","form_type":"4"}},{"id":1887026,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-19T01:00:07.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":25.4391,"value":635977.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0600 to $25.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,256 RSUs."}],"balance_after":32395,"source":{"system":"sec-edgar","filing":"0001209191-23-030857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123030857/doc4.xml","form_type":"4"}},{"id":1887025,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-19T01:00:07.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,256 RSUs."}],"balance_after":57395,"source":{"system":"sec-edgar","filing":"0001209191-23-030857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123030857/doc4.xml","form_type":"4"}},{"id":1959033,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-11T02:00:15.000Z","date":"2023-03-10","kind":"grant","acquired":false,"shares":51950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027;\nsubject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":51950,"derivative":{"exercise_price":24.07,"expiration_date":"2033-03-10","underlying":"Stock Option (Right to Buy)","underlying_shares":51950},"source":{"system":"sec-edgar","filing":"0001209191-23-018042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123018042/doc4.xml","form_type":"4"}},{"id":1959032,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:00:15.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":22925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each\nRSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March\n10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 31,256 RSUs."}],"balance_after":32395,"source":{"system":"sec-edgar","filing":"0001209191-23-018042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123018042/doc4.xml","form_type":"4"}},{"id":1959031,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:00:15.000Z","date":"2023-03-09","kind":"sale","acquired":false,"shares":505,"price":24.41,"value":12327.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the\nvesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not\nrepresent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,331 RSUs."}],"balance_after":9470,"source":{"system":"sec-edgar","filing":"0001209191-23-018042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123018042/doc4.xml","form_type":"4"}},{"id":2007973,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T02:00:17.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":58750,"derivative":{"exercise_price":0.1,"exercise_date":"2018-12-15","expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-010955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123010955/doc4.xml","form_type":"4"}},{"id":2007972,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-02-18T02:00:17.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":25000,"price":21.6894,"value":542235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.5000 to $21.9900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":9975,"source":{"system":"sec-edgar","filing":"0001209191-23-010955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123010955/doc4.xml","form_type":"4"}},{"id":2007971,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-02-18T02:00:17.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":34975,"source":{"system":"sec-edgar","filing":"0001209191-23-010955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123010955/doc4.xml","form_type":"4"}},{"id":2054857,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-14T02:00:25.000Z","date":"2023-01-12","kind":"exercise","acquired":false,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":83750,"derivative":{"exercise_price":0.1,"exercise_date":"2018-12-15","expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-003385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123003385/doc4.xml","form_type":"4"}},{"id":2054856,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-01-14T02:00:25.000Z","date":"2023-01-12","kind":"sale","acquired":false,"shares":25000,"price":25.5723,"value":639307.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5000 to $25.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":9975,"source":{"system":"sec-edgar","filing":"0001209191-23-003385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123003385/doc4.xml","form_type":"4"}},{"id":2054855,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-01-14T02:00:25.000Z","date":"2023-01-12","kind":"exercise","acquired":true,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":34975,"source":{"system":"sec-edgar","filing":"0001209191-23-003385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919123003385/doc4.xml","form_type":"4"}},{"id":2114734,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T01:00:11.000Z","date":"2022-11-14","kind":"exercise","acquired":false,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":108750,"derivative":{"exercise_price":0.1,"exercise_date":"2018-12-15","expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-057418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919122057418/doc4.xml","form_type":"4"}},{"id":2114733,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-11-17T01:00:11.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":25000,"price":24.2672,"value":606680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from\n$23.8000 to $24.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the\nSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote."}],"balance_after":9975,"source":{"system":"sec-edgar","filing":"0001209191-22-057418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919122057418/doc4.xml","form_type":"4"}},{"id":2114732,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-11-17T01:00:11.000Z","date":"2022-11-14","kind":"exercise","acquired":true,"shares":25000,"price":0.1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":34975,"source":{"system":"sec-edgar","filing":"0001209191-22-057418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919122057418/doc4.xml","form_type":"4"}},{"id":2131709,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-26T22:03:36.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":23000,"derivative":{"exercise_price":9.834,"expiration_date":"2032-10-24","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-054666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919122054666/doc4.xml","form_type":"4"}},{"id":2131708,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-10-26T22:03:36.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 RSUs."}],"balance_after":9975,"source":{"system":"sec-edgar","filing":"0001209191-22-054666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000120919122054666/doc4.xml","form_type":"4"}},{"id":2340064,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T01:26:58.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":50650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":50650,"derivative":{"exercise_price":19.15,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":50650},"source":{"system":"sec-edgar","filing":"0001567619-22-006733","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922006733/doc1.xml","form_type":"4"}},{"id":2340063,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-03-11T01:26:58.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":6575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting.  The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,575 RSUs."}],"balance_after":6575,"source":{"system":"sec-edgar","filing":"0001567619-22-006733","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922006733/doc1.xml","form_type":"4"}},{"id":2350680,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T22:23:25.000Z","date":"2022-03-02","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":124149,"derivative":{"exercise_price":1.05,"exercise_date":"2022-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-22-006400","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922006400/doc1.xml","form_type":"4"}},{"id":2350679,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-03-04T22:23:25.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":25000,"price":20.822,"value":520550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.35 to $21.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-006400","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922006400/doc1.xml","form_type":"4"}},{"id":2350678,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-03-04T22:23:25.000Z","date":"2022-03-02","kind":"exercise","acquired":true,"shares":25000,"price":1.05,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001567619-22-006400","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922006400/doc1.xml","form_type":"4"}},{"id":2404537,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":3873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":149149,"derivative":{"exercise_price":1.05,"exercise_date":"2022-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":3873},"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2404536,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":21127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":153022,"derivative":{"exercise_price":1.05,"exercise_date":"2022-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":21127},"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2404535,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":3873,"price":20.1605,"value":78081.6165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2404534,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":3873,"price":1.05,"value":4066.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":3873,"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2404533,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":21127,"price":20.0165,"value":422888.5955,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.10 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2404532,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-02-10T22:08:41.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":21127,"price":1.05,"value":22183.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":21127,"source":{"system":"sec-edgar","filing":"0001567619-22-003261","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922003261/doc1.xml","form_type":"4"}},{"id":2436957,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":6414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 23, 2022."}],"balance_after":174149,"derivative":{"exercise_price":1.05,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":6414},"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436956,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":2424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 22, 2023."}],"balance_after":33820,"derivative":{"exercise_price":1.57,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":2424},"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436955,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-10","kind":"exercise","acquired":false,"shares":30631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 22, 2023."}],"balance_after":36244,"derivative":{"exercise_price":1.57,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":30631},"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436954,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-10","kind":"exercise","acquired":false,"shares":8231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023."}],"balance_after":46993,"derivative":{"exercise_price":1.57,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":8231},"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436953,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":8838,"price":20.1229,"value":177846.1902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.34 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436952,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":6414,"price":1.05,"value":6734.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":8838,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436951,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":2424,"price":1.57,"value":3805.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2424,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436950,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":38862,"price":20.1619,"value":783531.7578,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.62 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436949,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-10","kind":"exercise","acquired":true,"shares":30631,"price":1.57,"value":48090.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":38862,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2436948,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-13T01:01:18.000Z","date":"2022-01-10","kind":"exercise","acquired":true,"shares":8231,"price":1.57,"value":12922.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":8231,"source":{"system":"sec-edgar","filing":"0001567619-22-001142","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922001142/doc1.xml","form_type":"4"}},{"id":2444457,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023."}],"balance_after":55224,"derivative":{"exercise_price":1.57,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444456,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023."}],"balance_after":56024,"derivative":{"exercise_price":1.57,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444455,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023."}],"balance_after":56524,"derivative":{"exercise_price":1.57,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444454,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":800,"price":20.0225,"value":16018.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444453,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":800,"price":1.57,"value":1256.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444452,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":500,"price":20,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444451,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":500,"price":1.57,"value":785.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444450,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1000,"price":20.021,"value":20021.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.06 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2444449,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2022-01-06T01:57:01.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":1000,"price":1.57,"value":1570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001567619-22-000672","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761922000672/doc1.xml","form_type":"4"}},{"id":2515514,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-13T00:00:05.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023."}],"balance_after":57524,"derivative":{"exercise_price":1.57,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-21-020114","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761921020114/doc1.xml","form_type":"4"}},{"id":2515513,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2021-11-13T00:00:05.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":440,"price":22.1981,"value":9767.164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.26  inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-020114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761921020114/doc1.xml","form_type":"4"}},{"id":2515512,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2021-11-13T00:00:05.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":24560,"price":21.5254,"value":528663.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $22.13 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":440,"source":{"system":"sec-edgar","filing":"0001567619-21-020114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761921020114/doc1.xml","form_type":"4"}},{"id":2515511,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing"}}],"security":"Common Stock","published_at":"2021-11-13T00:00:05.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":25000,"price":1.57,"value":39250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001567619-21-020114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000156761921020114/doc1.xml","form_type":"4"}},{"id":2739745,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-27T00:59:27.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":66875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025; subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":66875,"derivative":{"exercise_price":17,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":66875},"source":{"system":"sec-edgar","filing":"0000899243-21-017032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000089924321017032/doc4.xml","form_type":"4"}}]}